conference room


Oregon's state society was among the country's first, and was originally formed as a patient advocacy group.

The purpose of OSMO shall be:

  • To promote the highest professional standards of Oncology in the state of Oregon;
  • To study, research and exchange information, experiences and ideas leading to improvement in Oncology.

In order to carry out these interests, some of the goals for the Society include:

  • Affect legislation and public policy relative to patient access to cancer care
  • Act as a resource on the "accepted medical practices" associated with cancer care
  • Provide a forum for education of our members on current technologies and their role as accepted medical practices
  • Provide communications to our members and others on issues affecting patient access to cancer care and the practice of oncology


Liz Cleland
Executive Vice President
1325 Officers Row Suite A
Vancouver, WA 98661
please email questions to
Fax: 360.326.1733

Officers 2017-2019

James L. Gajewski, MD, MACP
President 2017-2019
Portland, OR

David Hufnagel, DO
Samaritan Hematology & Oncology Consultants
President Elect

Benjamin L. Cho, MD
Immediate Past President
Willamette Valley Cancer Institute
Eugene, OR

Kevin W. H. Yee, MD
Tualatin, OR and Beaverton, OR

Board of Directors 2017-2019

Anupama Kurup Acheson, MD
Providence Oncology
Portland, OR

Gerald Ahmann, MD
Emeritus Hematology Oncology Associates
Medford, OR

Holly Almond, MSN, FNP
Samaritan Hematology & Oncology Consultants

Charles David Blanke, MD, FACP, FASCO
Knight Cancer Institute and OHSU
Portland, OR

William Schmidt, MD
Bend Memorial Clinic
Bend, OR

Christopher Crum, PA_C
Hematology Oncology Associates
Medford, OR

Lucy Langer, MD
Compass Oncology

Matthew Lonergan, MD
Willamette Valley Cancer Institute
Eugene, OR

Mujahid Rizvi, MD, MPH, FACP
Hematology Oncology Associates

John M. Strother, MD
Hematology Oncology of Salem
Salem, OR

OSMO is a State Affiliate Member of ASCO